These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 9455325)
1. A prescription refill causes a problem. Lilley LL; Guanci R Am J Nurs; 1998 Jan; 98(1):12-4. PubMed ID: 9455325 [No Abstract] [Full Text] [Related]
2. Seizures caused by concomitant use of lindane and dextroamphetamine in a child with attention deficit hyperactivity disorder. Cox R; Krupnick J; Bush N; Houpt A J Miss State Med Assoc; 2000 Aug; 41(8):690-2. PubMed ID: 10974795 [No Abstract] [Full Text] [Related]
3. Letter to the editor: Comment on 'Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder'. Olders H J Pediatr Psychol; 2009; 34(1):108-9; author reply 110-2. PubMed ID: 19136567 [No Abstract] [Full Text] [Related]
4. [Central nervous system stimulants and their potential risk of abuse in hyperkinetic disorders]. Aanonsen NO Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4040-2. PubMed ID: 10613094 [TBL] [Abstract][Full Text] [Related]
5. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications. Varley CK; Vincent J; Varley P; Calderon R Compr Psychiatry; 2001; 42(3):228-33. PubMed ID: 11349243 [TBL] [Abstract][Full Text] [Related]
9. Insomnia, night terror, and depression related to clonidine in attention-deficit/hyperactivity disorder. Ghanizadeh A J Clin Psychopharmacol; 2008 Dec; 28(6):725-6. PubMed ID: 19011458 [No Abstract] [Full Text] [Related]
10. [Substitution of dexamethasone for dexamphetamine due to their written and spoken similarity]. Hoppenbrouwers CJ; Mooren GC; van den Heuvel JJ; Op de Coul ME; van Trotsenburg PA Ned Tijdschr Geneeskd; 2010; 154():A1662. PubMed ID: 20858310 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of risks associated with short- and long-term psychostimulant therapy for treatment of ADHD in children. Kociancic T; Reed MD; Findling RL Expert Opin Drug Saf; 2004 Mar; 3(2):93-100. PubMed ID: 15006715 [TBL] [Abstract][Full Text] [Related]
17. Are stimulants overprescribed? Perry R; Gilbert EM; Angkustsiri K J Am Acad Child Adolesc Psychiatry; 2000 Mar; 39(3):269-70; author reply 270-1. PubMed ID: 10714041 [No Abstract] [Full Text] [Related]
18. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion. Faraone SV; Wilens TE J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377 [TBL] [Abstract][Full Text] [Related]
19. Response to Calver et al. on the WA regulatory scheme for stimulants. Stevens M Aust N Z J Public Health; 2008 Apr; 32(2):182. PubMed ID: 18412693 [No Abstract] [Full Text] [Related]
20. Another long-acting methylphenidate (Metadate CD). Med Lett Drugs Ther; 2001 Oct; 43(1114):83-4. PubMed ID: 11581582 [No Abstract] [Full Text] [Related] [Next] [New Search]